In 2011 this blog was listed as one of the top 10 blog in pharma technical information it is popular amongst the pharmacists and pharma industry professionals. We have published very important and very useful information for pharma industry professionals.

Sunday, January 2, 2022

Dextromethorphan a drug used in Cough Syrup to supression of coughing action helps corona Virus SARS-COV-2 growth research paper published by Indian scientists supports observation in an research published, Opoids is associated with higher mortality in Corona Positive Patients

Dextromethorphan a drug which is an analog of morphine and consist the main maopholine ring in its molecule which is also part of all opoid drungs.

It is found that the Sigma1 sites on the viral particles are bind with Dextromethorphan in a manner that helps virus to replicate.
Also the lysosome which impart cellular Imunity by embibing and dissolving viral particles, formed are smaller in size so that they are not effective against SARS-COV-2 viral particle vessicals. 
Also there are some research findings on Opoid drugs usage and high mortality rate in patients given opoids for treatment of pain management.
Opoids are consided to be suppressing immunity ER lysosomal cellular protection mechanis is hampered by the Opoids.

There for treatment of SARS-COV-2 Positive patients drug that contains dextromethorphan or any opoidal anasthetic drug should be avoided, use of such agent should be done based on risk based approach.

On the other hand drug Haloperidol which is used in treatment of mental disorder is found to be blocking virus replication there for this drug may be a good candidate for the treatment of SARS-COV-2 .
Also these studies require Clinical evaluation through Clinical trials.
How ever looking at the reserch outcome it is recommended that dextromethorphan containg cough Syrup should be avoided for COVID 19 positive patients.

There are other Cough Syrups containing, Ambroxol, Guaphenasin, Bomohexine Hydrochloride Containg Cough Syrups, it should be started 5 ml Thice a day for positive patients even if there is no cough because it take three to four dose to show mucolytic activity, mucolytic activity is also hamper Virus growth and protect from damage to lungs due to coghing action.

Dextromethorphan should be contraindicated for COVId 19
Reference: 

No comments:


What is 21 CFR Part 11, US FDA guidelines requirements of FDA compliance and CFR 21 Part 11.

What is a Site Master file of a pharmaceutical company

What is Generic Drug

What is Reference Listed Drug  ? ( RLD )

What is Pharmaceutical Equivalents

What is Pharmaceutical Alternatives

What is Therapeutic Equivalents

What are Post Market studies

Why a drug is bound to protein, What is protein binding?  What is drug absorption , distribution ?

Do Physical properties contribute to drug activity.

What is drug receptor , How a drug resistance occurs

Mechanism of drug resistance

What is drug interaction

Drug interaction, and its examples

What is first pass metabolism of a drug

What is What is 510(k) Clearances ?

What is 510(k) Clearances,

Premarket Notification for medical devices - PMN or 510(k)

What is a drug interaction

Examples of drug interactions


Antibiotic Definition and classification


Antibiotic Resistance and Antibiotic resistance mechanism

Antioxidants food supplements

Vitamin D Details on FDA cautions on accurate dosage of Vitamin D


What is an antibody? what is monoclonal and polyclonal antibodies?

Terminologies In vaccine Production

Multi stage testing of Virus vaccine production

Testing of vaccines at different stages of production

TESTING FOR ADVENTITIOUS AGENTS CELL PROPERTIES IN VIRAL VACCINE PRODUCTION

Enzyme linked immunosorbent assay ELISA

Raido Immuno assay

http://whoguideline.blogspot.com/2010/04/terminalogy-and-their-explanations.html

Pharmaceutical Aseptic Manufacturing Process Terms , Terminology and Definitions.

http://whoguideline.blogspot.com/2010/02/pharmaceutical-aseptic-manufacturing.html

Here are some articles which will be useful for you in further understanding of aspects of sterile dosage form manufacturing and regulatory affairs and good manufacturing practice in

pharmaceutical industry

Pharmaceutical Validation

Types of validations in pharmaceutical manufacturing


Requirements of documents for validation of sterilisation process

How to investigate OOS out of specification results

Determination of Phenol coefficient of a disinfectant

Sterility testing

Clean Room Classification

Time limitations in sterile pharmaceuticals processing

Aspects of validation of manufacturing process in sterile pharmaceuticals

Clinical Trials

Requirements of US FDA Inspections of Clinical Investigators of Clinical Trials

PROCEDURE OF AN INSPECTIONS OF CLINICAL TRIAL INVESTIGATOR BY US FDA HOW ARE CLINICAL INVESTIGATOR INSPECTIONS CONDUCTED?

US FDA INSPECTION OF CLINICAL INVESTIGATORS OUT OF UNITED STATES OF AMERICA

REPORTS AFTER AN INSPECTION OF A INVESTIGAOTR OF CLINICAL TRIALS

Controlling Pyrogens in injectable dosage forms

Media fill run process simulation aspects Validation of Aseptic Process and Sterilisation

New Drug Application (NDA) how to make a New Drug Application (NDA) to US FDA

Abbreviated New Drug Application (ANDA) What is ANDA , detailed information about ANDA preparation and submission to US FDA

How to make Investigational New Drug (IND) Application to US FDA

Drug applications submission to us fda Over the counter Drugs OTC drugs

BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS

Electronic record in pharmaceutical manufacturing industry

Good manufacturing practice in pharmaceutical industry

Pharmaceutical industry pharmaceutical companies and FDA latest updates